Body mass index changes after fecal microbiota transplantation for recurrent infection
Background: Fecal microbiota transplantation (FMT) is a successful therapy for Clostridioides difficile infection (CDI). FMT from overweight donors is speculated to influence the recipient’s body mass index (BMI) after administration for CDI. Objectives: We investigated changes in the recipient’s BM...
Saved in:
| Main Authors: | Kanika Sehgal, Parul Berry, Janice Cho, George Saffouri, Ross A. Dierkhising, Eric Battaglioli, Purna C. Kashyap, Darrell Pardi, Sahil Khanna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251321121 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world use of bezlotoxumab to prevent recurrent infections: a single-center experience and meta-analysis
by: Kanika Sehgal, et al.
Published: (2025-06-01) -
Factors associated with failure of fecal microbiota transplant for recurrent infection
by: Joseph D. K. Nguyen, et al.
Published: (2025-04-01) -
Characteristics and Real-World Outcomes of Patients Treated with Fecal Microbiota, Live-jslm (RBL) for the Prevention of Recurrent Clostridioides difficile Infection
by: Sahil Khanna, et al.
Published: (2025-03-01) -
Physician Attitudes toward the Use of Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium difficile Infection
by: Jonathan S Zipursky, et al.
Published: (2014-01-01) -
Fecal microbiota transplantation: present and future
by: Ra Ri Cha, et al.
Published: (2025-05-01)